Clinical Trial Update: CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients? [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing CAR-T cell therapy versus autologous stem cell transplant for newly diagnosed multiple myeloma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Xuzhou Medical University | Conditions: Multiple Myeloma, Newly Diagnosed | Phase 2 | Status: NOT_YET_RECRUITING